Voice diseases have been increasing dramatically in recent times due mainly to unhealthy social habits and voice abuse. These diseases must be diagnosed and treated at an early stage, especially in the case of larynx cancer. It is widely recognized that vocal and voice diseases do not necessarily cause changes in voice quality as perceived by a listener. Acoustic analysis could be a useful tool to diagnose this type of disease. Preliminary research has shown that the detection of voice alterations can be carried out by means of Gaussian mixture models and short-term mel cepstral parameters complemented by frame energy together with first and second derivatives. This paper, using the F-Ratio and Fisher's discriminant ratio, will demonstrate that the detection of voice impairments can be performed using both mel cepstral vectors and their first derivative, ignoring the second derivative

It is well known that vocal and voice diseases do not necessarily cause perceptible changes in the acoustic voice signal. Acoustic analysis is a useful tool to diagnose voice diseases being a complementary technique to other methods based on direct observation of the vocal folds by laryngoscopy. Through the present paper two neural-network based classification approaches applied to the automatic detection of voice disorders will be studied. Structures studied are multilayer perceptron and learning vector quantization fed using short-term vectors calculated accordingly to the well-known Mel Frequency Coefficient cepstral parameterization. The paper shows that these architectures allow the detection of voice disorders-including glottic cancer-under highly reliable conditions. Within this context, the Learning Vector quantization methodology demonstrated to be more reliable than the multilayer perceptron architecture yielding 96% frame accuracy under similar working conditions.

Current standard protocols used in the clinic for diagnosing COVID-19 include molecular or antigen tests, generally complemented by a plain chest X-Ray. The combined analysis aims to reduce the significant number of false negatives of these tests and provide complementary evidence about the presence and severity of the disease. However, the procedure is not free of errors, and the interpretation of the chest X-Ray is only restricted to radiologists due to its complexity. With the long term goal to provide new evidence for the diagnosis, this paper presents an evaluation of different methods based on a deep neural network. These are the first steps to develop an automatic COVID-19 diagnosis tool using chest X-Ray images to differentiate between controls, pneumonia, or COVID-19 groups. The paper describes the process followed to train a Convolutional Neural Network with a dataset of more than 79, 500 X-Ray images compiled from different sources, including more than 8, 500 COVID-19 examples. Three different experiments following three preprocessing schemes are carried out to evaluate and compare the developed models. The aim is to evaluate how preprocessing the data affects the results and improves its explainability. Likewise, a critical analysis of different variability issues that might compromise the system and its effects is performed. With the employed methodology, a 91.5% classification accuracy is obtained, with an 87.4% average recall for the worst but most explainable experiment, which requires a previous automatic segmentation of the lung region.